Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | VCAM1 | P19320 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.37 |
| ▸ | MERTK | Q12866 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3636393 | 0.89 | MAPT (0.39) | MAPTVCAM1MERTKCYP19A1ALDH1A1 | |
| SCHEMBL3035964 | 0.88 | CYP3A4 (0.48) | MAPTVCAM1CYP3A4EPAS1MERTK | |
| SCHEMBL3640136 | 0.82 | MAPT (0.35) | MAPTVCAM1MERTKCYP19A1ALDH1A1 | |
| SCHEMBL3640130 | 0.82 | MAPT (0.35) | MAPTVCAM1MERTKCYP19A1ALDH1A1 | |
| SCHEMBL3642514 | 0.82 | CYP1A2 (0.39) | MAPTCYP3A4ALDH1A1HPGDCYP2C9 | |
| SCHEMBL4268207 | 0.81 | VCAM1 (0.42) | MAPTVCAM1CYP3A4EPAS1MERTK | |
| SCHEMBL3640135 | 0.81 | MAPT (0.35) | MAPTALDH1A1HPGDMAPK1HTT | |
| SCHEMBL13492243 | 0.80 | MAPT (0.42) | MAPTVCAM1CYP3A4EPAS1MERTK | |
| SCHEMBL3936873 | 0.79 | SMN1; SMN2 (0.41) | MAPTCYP3A4ALDH1A1HPGDCYP2C9 | |
| SCHEMBL3637633 | 0.79 | CYP3A4 (0.48) | CYP3A4EPAS1CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8304419-B2 | Chemical compounds | GLAXOSMITHKLINE LLC (US) | 2012-11-06 | — | — | US | disclosed |
| EP-2166856-A1 | CHEMICAL COMPOUNDS | GlaxoSmithKline LLC (US) | 2010-03-31 | — | — | EP | disclosed |
| WO-2008154271-A1 | CHEMICAL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2008-12-18 | — | — | WO | disclosed |